MedPath

Effect of potassium rich diet in patients with ulcerative colitis

Phase 4
Conditions
Health Condition 1: K638- Other specified diseases of intestine
Registration Number
CTRI/2019/03/018217
Lead Sponsor
Dept of Gastroenterology
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Closed to Recruitment of Participants
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patients who are confirmed cases of mild ulcerative colitis (of any disease extent) as assessed by Mayo score (4-6), within 1 week of relapse

2.Age: 18 â?? 70 years of either gender

3.Patients on stable dose of mesalamine for past 4 weeks

4.Patients on stable dose of azathiopurine/ 6-mercaptopurine for past 6 months

5.Ready to participate

Exclusion Criteria

1.H/O of oral steroids in the past 4 weeks

2.H/O or oral antibiotics within past 2 weeks

3.H/O topical therapy within 1 week

4.Patients with severe disease activity

5.Patients with fulminant colitis requiring hospitalization

6.Patients who have had surgery

7.Patients with Crohnâ??s colitis

8.Patients with concomitant GI infection

9.Patients on drugs that can affect potassium homeostasis (ACE-inhibitors, angiotensin receptor blockers, aldosterone antagonists)

10.Patients with comorbidities like acute myocardial infarction, chronic kidney disease or chronic liver disease or any other condition which precludes high potassium diet

11.Patients with significant hepatic, renal, endocrine, respiratory, neurologic, or cardiovascular diseases will also be excluded

12.Pregnant, lactating females

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Clinical remission at 8 weeks, defined as Mayo score â?¤2 with all sub-scores â?¤1.Timepoint: at 8 weeks
Secondary Outcome Measures
NameTimeMethod
1.Clinical response at 8 weeks, defined as reduction in Mayo score by more than 3 points or by 30 percent reduction in Mayo score from baseline. <br/ ><br>2.Treatment failure, defined as increase in Mayo score by more than 3 points with all sub scores more than 1. <br/ ><br>3.Adverse events at 8 weeks <br/ ><br>Timepoint: At 8 weeks
© Copyright 2025. All Rights Reserved by MedPath